WHO says ‘more information’ required from Bharat Biotech for emergency use listing of Covaxin
The Hindu
A pre-submission meeting is expected “to be planned May-June 2021,” the guidance document said.
The World Health Organisation (WHO) said “more information” is “required” from Bharat Biotech, which is seeking emergency use listing (EUL) for its . The latest guidance document dated May 18 on the WHO website said Bharat Biotech submitted EOI (Expression of Interest) on April 19 and that “More information required”. A pre-submission meeting is expected “to be planned May-June 2021,” the guidance document said. According to the WHO, submissions to it for prequalification or listing under the emergency use procedure are confidential.More Related News